Celavie Biosciences to Present at April 2020 Virtual Investor Summit
OXNARD, Calif.–(BUSINESS WIRE)–Celavie Biosciences, LLC, a company working to improve lives and restore hope by advancing innovations in CNS diseases with regenerative stem cell-based therapies, today announced that the Company will give a corporate presentation at the April 2020 Virtual Investor Summit, taking place online from April 22-23, 2020. Sandy Solmon, the Company’s President and Chief Executive Officer, will also give a corporate overview and update on recent momentum at Celavet Inc., a subsidiary of Celavie Biosciences that develops stem cell-based therapies for the treatment and prevention of orthopedic injuries and diseases in large and small animals. The presentation will take place on Thursday, April 23, 2020 at 1:00pm ET, followed by a live Q&A session with registered investors and other conference attendees.
